The present invention provides a drug that is effective in treating and/or completely curing dermatophytosis with ease. More specifically, the present invention provides a dermatophytosis pharmaceutical composition characterized in that it is topically applied and includes, as a main active ingredient, at least one organic acid salt selected from the group consisting of ethylenediaminetetraacetic acid salts.
